Speed of Onset and Efficacy of Sumatriptan Fast-Disintegrating/ Rapid-Release Tablets: Results of a Randomised, Placebo-Controlled Study Conducted in the USA and Canada

By Cady R.   Adelman J.   Taylor F.   Boudreau G.   Few C.   Webster C.  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 281-284

Informa Healthcare

Access to resources Recommend Favorite

Speed of Onset and Efficacy of Sumatriptan Fast-Disintegrating/ Rapid-Release Tablets: Pooled Results of Two Replicate, Randomised, PlaceboControlled Studies

By Dahlöf C.   Cady R.   Poole A.C.   Brandes J.   Few C.   Jones M.  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 277-280

Informa Healthcare

Access to resources Recommend Favorite

Time to onset of efficacy of the fast-disintegrating/rapid-release formulation of sumatriptan tablets in the acute treatment of migraine

By Agosti Reto   Dahlöf Carl G.H.   Mulleners Wim M.   Jones Martin W.   Webster Chris   Few Colleen  

Headache Care, Vol. 3, Iss. 1, 2006-07 ,pp. : 3-10

Informa Healthcare

Access to resources Recommend Favorite

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

By Rösler Michael   Fischer Roland   Ammer Richard   Ose Claudia   Retz Wolfgang  

European Archives of Psychiatry and Clinical Neuroscience, Vol. 259, Iss. 2, 2009-02 ,pp. : 120-129

Springer Publishing Company

Access to resources Recommend Favorite